North America $14.69 Billion Antibiotics Markets, 2020-2030

Dublin, Sept. 11, 2020 (GLOBE NEWSWIRE) -- The "North America Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

North America antibiotics market is expected to grow by 2.3% annually in the forecast period and reach $14.67 billion by 2030 driven by rising incidences of bacterial infection, growing awareness and need for new drugs and treatment amid the COVID-19 epidemic.

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Country.

For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Drug Class, Drug Origin, and Route of Administration over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

• Abbott Laboratories

• Astellas Pharma

• AstraZeneca Plc

• Bayer AG

• Bristol Myers Squibb Company

• Cipla Inc.

• Dr. Reddy's Laboratories Ltd.

• Eli Lilly and Company

• F. Hoffmann-La Roche Ltd.

• Gilead Sciences, Inc.

• GlaxoSmithKline plc.

• Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)

• Mayne Pharma Group Ltd.

• MELINTA THERAPEUTICS, INC.

• Merck KGaA

• Novartis AG

• Pfizer Inc.

• Sanofi

• Sun Pharmaceutical Industries Ltd.

Key Topics Covered:

1 Introduction
1.1 Industry Definition and Research Scope
1.2 Research Methodology
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's five Forces Analysis

3 Segmentation of North America Market by Drug Class
3.1 Market Overview by Drug Class
3.2 Cephalosporin
3.3 Penicillin
3.4 Macrolides
3.5 Fluoroquinolones
3.6 Quinolones
3.7 Monobactam
3.8 Aminoglycosides
3.9 Carbapenem
3.10 Other Drug Classes

4 Segmentation of North America Market by Action Mechanism
4.1 Market Overview by Action Mechanism
4.2 Cell Wall Synthesis Inhibitors
4.3 Mycolic Acid Inhibitors
4.4 RNA Synthesis Inhibitors
4.5 DNA Synthesis Inhibitors
4.6 Protein Synthesis Inhibitors
4.7 Other Mechanisms

5 Segmentation of North America Market by Drug Origin
5.1 Market Overview by Drug Origin
5.2 Natural Antibiotics
5.3 Semi-synthetic Antibiotics
5.4 Synthetic Antibiotics

6 Segmentation of North America Market by Activity Spectrum
6.1 Market Overview by Activity Spectrum
6.2 Broad-spectrum Antibiotics
6.3 Narrow-spectrum Antibiotics

7 Segmentation of North America Market by Route of Administration
7.1 Market Overview by Route of Administration
7.2 Oral Administration
7.3 Intravenous Administration
7.4 Other Administration Routes

8 Segmentation of North America Market by Drug Type
8.1 Market Overview by Drug Type
8.2 Brand Antibiotics
8.3 Generic Antibiotics

9 North America Market 2019-2030 by Country
9.1 Overview of North America Market
9.2 U.S.
9.3 Canada
9.4 Mexico

10 Competitive Landscape
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/3rc1x4

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900